Choosing & Using Fragments in the Generation of Selective Kinase Inhibitors

Video   Oct 06, 2016

 

There is often a debate about just how useful fragments are for well-established conventional targets such as protein kinases. Fragment screening however can be extremely valuable, providing critical ideas that lead to novelty, demonstrating how to achieve selectivity, helping dissect and make the most of HTS and literature compounds, alongside maximising ligand efficiency.Finding fragments that bind to such targets is straight-forward. For most kinases, a screen of our 1350 member fragment library results in between 40 to 170 validated and chemically distinct hits. In addition, crystal structures for these hits bound to the kinase can usually be obtained quite rapidly. The real challenge is how to digest all this information and decide how and which fragments to progress in order to identify the highest quality leads. My presentation will illustrate the approach taken at Vernalis in some recent projects which led to the discovery of novel lead series for a number of different kinases. The main messages are that: fragments always tell you something new about the binding site; careful triage and exploration of fragment SAR can give indications of how to achieve selectivity, novelty and affinity;it is important to optimise the fragment before investing large chemistry resources and that with patience, a fragment derived series will often supersede an HTS derived series and deliver a better quality of compound for lead optimisation.

 
Company Information
 
 
 

Recommended Videos

Behind the Science, S3 Ep 1: Exploring new dimensions in chromatography with Claude Mallet

Video

To kick off season 3 of Behind the Science, our host Jen Fournier meets Claude Mallet of Waters at his new multi-dimensional chromatography lab to break down the myths of 2D LC, also known as LCxLC.

WATCH NOW

Claisse® LeDoser 12™ Instrument - Just-in-time weighing for optimal precision and repeatability!

Video

LeDoser-12 is a robust instrument that does not get tired or distracted; it can work in harsh work conditions and always provides the same repeatability.

WATCH NOW

Contrasting LBAs and LC-MS for Peptide and Protein Bioanalysis

Video

Kelly Doering discusses ligand binding assays (LBAs) and compares the advantages and limitations of this technology to LC-MS.

WATCH NOW

 

Comments | 0 ADD COMMENT

Like what you just watched? You can find similar content on the communities below.

Analysis & Separations Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE